P95

P95 is a specialized, global Contract Research Organization (CRO) focused exclusively on vaccines and infectious diseases, offering integrated clinical trial and epidemiological research services. With over 25 years of collective experience, 500 staff, and operations across five continents, the company differentiates itself through deep expertise in challenging environments, particularly in Africa and LMICs. Its business model is service-based, generating revenue by supporting pharmaceutical companies, biotechs, and global health organizations through all phases of clinical development and post-marketing studies. P95 appears to be a mature, revenue-generating private company built through the integration of several legacy CROs.

Integrated service model combining clinical trial operations, epidemiological research, and real-world evidence (RWE) generation, with specialized operational expertise for conducting studies in Africa and low- to middle-income countries (LMICs).

Competes against large, full-service CROs (e.g., IQVIA, ICON, Labcorp) that have vast resources, and against other specialized boutique CROs focusing on infectious diseases or specific regions. Differentiation is achieved through deep, exclusive focus on vaccines/infectious diseases and proven, on-the-ground expertise in Africa and LMICs, a combination not all competitors offer.